Zhang R - Search Results

1

A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin.

Zhang R, Yang X, Roque DM, Li C, Lin J. Zhang R, et al. PLoS One. 2021 Apr 28;16(4):e0240145. doi: 10.1371/journal.pone.0240145. eCollection 2021. PLoS One. 2021. PMID: 33909625 Free PMC article.

2

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.

Wei J, Ma L, Lai YH, Zhang R, Li H, Li C, Lin J. Wei J, et al. Among authors: zhang r. J Exp Clin Cancer Res. 2019 Feb 8;38(1):63. doi: 10.1186/s13046-019-1072-8. J Exp Clin Cancer Res. 2019. PMID: 30736824 Free PMC article.

3

Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.

Tian J, Chen X, Fu S, Zhang R, Pan L, Cao Y, Wu X, Xiao H, Lin HJ, Lo HW, Zhang Y, Lin J. Tian J, et al. Among authors: zhang r, zhang y. Breast Cancer Res Treat. 2019 Jun;175(3):553-566. doi: 10.1007/s10549-019-05183-2. Epub 2019 Mar 9. Breast Cancer Res Treat. 2019. PMID: 30852762

4

Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.

Wei J, Ma L, Lai YH, Zhang R, Li H, Li C, Lin J. Wei J, et al. Among authors: zhang r. J Exp Clin Cancer Res. 2019 Aug 23;38(1):374. doi: 10.1186/s13046-019-1381-y. J Exp Clin Cancer Res. 2019. PMID: 31443669 Free PMC article.

5

A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.

Zhang R, Chen X, Fu S, Xu L, Lin J. Zhang R, et al. Oncol Rep. 2020 Sep;44(3):1224-1232. doi: 10.3892/or.2020.7667. Epub 2020 Jun 29. Oncol Rep. 2020. PMID: 32705214

6

LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells.

Chen X, Pan L, Wei J, Zhang R, Yang X, Song J, Bai RY, Fu S, Pierson CR, Finlay JL, Li C, Lin J. Chen X, et al. Among authors: zhang r. Sci Rep. 2021 Mar 22;11(1):6517. doi: 10.1038/s41598-021-85888-x. Sci Rep. 2021. PMID: 33753770 Free PMC article.

7

Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation.

Zhang R, Wang T, Lin J. Zhang R, et al. Anticancer Res. 2021 May;41(5):2277-2286. doi: 10.21873/anticanres.15003. Anticancer Res. 2021. PMID: 33952453

8

STAT3 inhibitor in combination with irradiation significantly inhibits cell viability, cell migration, invasion and tumorsphere growth of human medulloblastoma cells.

Pan L, Zhang R, Ma L, Pierson CR, Finlay JL, Li C, Lin J. Pan L, et al. Among authors: zhang r. Cancer Biol Ther. 2021 Sep 2;22(7-9):430-439. doi: 10.1080/15384047.2021.1951573. Epub 2021 Jul 13. Cancer Biol Ther. 2021. PMID: 34254873 Free PMC article.

9

Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth.

Zhang R, Roque DM, Reader J, Lin J. Zhang R, et al. Int J Oncol. 2022 May;60(5):50. doi: 10.3892/ijo.2022.5340. Epub 2022 Mar 22. Int J Oncol. 2022. PMID: 35315502 Free PMC article.

10

Successful treatment of advanced ovarian cancer with anlotinib: a case report.

Zhang P, Ma L, Wang X, Zhang R, Dong Y. Zhang P, et al. Among authors: zhang r. J Int Med Res. 2020 Dec;48(12):300060520976824. doi: 10.1177/0300060520976824. J Int Med Res. 2020. PMID: 33284728 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,713 results

Search Page

Filters